Eagle Pharmaceuticals (EGRX) Stock Chart & Stock Price History $1.94 0.00 (0.00%) As of 05/15/2025 03:02 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsSustainabilityTrendsBuy This Stock Eagle Pharmaceuticals Stock Price Performance The Eagle Pharmaceuticals (EGRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 59.16%, with a year-to-date return of 288.00%. In the past month, the stock has increased 19.75%, reflecting recent market activity. As of the latest close, Eagle Pharmaceuticals traded at $1.94 with a market cap of $25.20 million and volume of 3,275 shares. Five years ago, the stock traded at $50.27, representing a 96.14% decrease over that period. At the time, it had a market cap of $707.86 million and a volume of 148,800 shares. Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.51%1 Month Performance+19.75%3 Month Performance+65.81%Year-To-Date Performance+288.00%1 Year Performance-59.16%5 Year Performance-96.14% EGRX Stock Chart for Friday, May, 16, 2025 EGRX Chart by TradingView Eagle Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2025$1.94$1.94$1.94$1.803,275 shs$25.20 million05/15/2025$1.94$1.94$1.94$1.803,275 shs$25.20 million05/14/2025$1.97$1.94-1.52%$1.94$1.941,514 shs$25.20 million05/13/2025$1.99$1.97-1.01%$1.97$1.602,317 shs$25.58 million05/12/2025$1.99$1.99$1.99$1.55754 shs$25.84 million05/09/2025$1.90$1.99+4.74%$1.99$1.70571 shs$25.84 million05/08/2025$1.90$1.90$1.90$1.751,601 shs$24.68 million05/07/2025$1.90$1.90$1.90$1.751,601 shs$24.68 million05/06/2025$1.97$1.90-3.55%$1.90$1.75201 shs$24.68 million05/05/2025$1.97$1.97$1.97$1.601,692 shs$25.58 million Get the Latest News and Ratings for EGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/02/2025$1.96$1.97+0.51%$1.97$1.601,692 shs$25.58 million05/01/2025$1.96$1.96$1.96$1.9614 shs$25.46 million04/30/2025$1.96$1.96$1.96$1.50808 shs$25.46 million04/29/2025$1.92$1.96+2.08%$1.96$1.50808 shs$25.46 million04/28/2025$1.70$1.92+12.94%$1.92$1.60616 shs$24.94 million04/25/2025$1.50$1.70+13.33%$1.90$1.7058,851 shs$22.08 million04/24/2025$1.97$1.50-23.86%$1.79$1.5030,505 shs$19.48 million04/23/2025$1.65$1.97+19.39%$2.00$1.7568,402 shs$25.58 million04/22/2025$1.80$1.65-8.33%$1.75$1.65501 shs$21.43 million04/21/2025$1.80$1.80$1.80$1.55280 shs$23.38 million04/18/2025$1.80$1.80$1.80$1.55280 shs$23.38 million04/17/2025$1.62$1.80+11.11%$1.80$1.55280 shs$23.38 million04/16/2025$1.80$1.62-10.00%$1.68$1.25506 shs$21.04 million04/15/2025$1.25$1.80+44.00%$1.80$0.88690 shs$23.38 million Related Companies COYA Stock Price Chart SGMT Stock Price Chart IVVD Stock Price Chart MGNX Stock Price Chart BDTX Stock Price Chart CTNM Stock Price Chart ENTX Stock Price Chart KYTX Stock Price Chart OPTN Stock Price Chart HLVX Stock Price Chart Receive EGRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eagle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EGRX) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredA New Wealth Divide Is Forming NowOver the years, my proprietary stock system has identified some of the biggest winners long before Wall Street...InvestorPlace | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored How much money will YOU make when gold hits $5,000?What if I told you there was a way to secure a shot at making asymmetric gains from gold’s current historic bu...Eagle Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EGRX Stock Free EGRX Stock Alerts